Jubilant Pharmova announces voluntary prepayment of US$ 75 million term loan
As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore
As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
EDQM has also issued a Certificate of Suitability for Allopurino
Accelerating sustainability in Indian pharma industry
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Subscribe To Our Newsletter & Stay Updated